The ubiquitin-proteasome pathway in health and disease of the nervous system

Trends in Neurosciences

Volumn 30, Issue 11, 2007, Pages 587-595

  Hegde, Ashok N ^a   Upadhya, Sudarshan C ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMPA RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PARKIN; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEASOME; SYNAPTOPHYSIN; SYNTAXIN; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN PROTEIN LIGASE E3;

ALZHEIMER DISEASE; ATAXIA; AUTOPHAGY; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; DENDRITIC CELL; DROSOPHILA; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GRACILE NUCLEUS; HAPPY PUPPET SYNDROME; HUNTINGTON CHOREA; NERVE DEGENERATION; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; UBIQUITINATION;

ALZHEIMER DISEASE; ANIMALS; ATAXIA; DISEASE MODELS, ANIMAL; HUMANS; NERVOUS SYSTEM; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 35748959676     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2007.08.005     Document Type: Review

References (73)

1. Reissner K.J., et al. Molecular nodes in memory processing: insights from Aplysia. Cell. Mol. Life Sci. 63 (2006) 963-974
2. Arnold J., et al. Ubiquitin and its role in neurodegeneration. Prog. Brain Res. 117 (1998) 23-34
3. Ciechanover A., and Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40 (2003) 427-446
4. Hegde A.N., and DiAntonio A. Ubiquitin and the synapse. Nat. Rev. Neurosci. 3 (2002) 854-861
5. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
6. Hegde A.N. Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog. Neurobiol. 73 (2004) 311-357
7. Cohen-Cory S. The developing synapse: construction and modulation of synaptic structures and circuits. Science 298 (2002) 770-776
8. Stegmuller J., et al. Cell-intrinsic regulation of axonal morphogenesis by the Cdh1-APC target SnoN. Neuron 50 (2006) 389-400
9. Lasorella A., et al. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth. Nature 442 (2006) 471-474
10. Kuo C.T., et al. Identification of E2/E3 ubiquitinating enzymes and caspase activity regulating Drosophila sensory neuron dendrite pruning. Neuron 51 (2006) 283-290
11. Hoopfer E.D., et al. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning. Neuron 50 (2006) 883-895
12. Schaefer H., and Rongo C. KEL-8 is a substrate receptor for CUL3-dependent ubiquitin ligase that regulates synaptic glutamate receptor turnover. Mol. Biol. Cell 17 (2006) 1250-1260
13. Bingol B., and Schuman E.M. Synaptic protein degradation by the ubiquitin proteasome system. Curr. Opin. Neurobiol. 15 (2005) 536-541
14. Kuo C.T., et al. Dendrite-specific remodeling of Drosophila sensory neurons requires matrix metalloproteases, ubiquitin-proteasome, and ecdysone signaling. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15230-15235
15. Watts R.J., et al. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron 38 (2003) 871-885
16. Zhai Q., et al. Involvement of the ubiquitin-proteasome system in the early stages of Wallerian degeneration. Neuron 39 (2003) 217-225
17. Kostovic, I. and Judas, M. Transient patterns of cortical lamination during prenatal life: Do they have implications for treatment? Neurosci. Biobehav. Rev. http://www.sciencedirect.com/science/journal/01497634 doi: 10.1016/j.neubiorev.2007.04.018
18. van Roessel P., et al. Independent regulation of synaptic size and activity by the anaphase-promoting complex. Cell 119 (2004) 707-718
19. Hoogenraad C.C., et al. Liprinalpha1 degradation by calcium/calmodulin-dependent protein kinase II regulates LAR receptor tyrosine phosphatase distribution and dendrite development. Dev. Cell 12 (2007) 587-602
20. Hegde A.N., et al. Regulatory subunits of cAMP-dependent protein kinases are degraded after conjugation to ubiquitin: a molecular mechanism underlying long-term synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7436-7440
21. Hegde A.N., et al. Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 89 (1997) 115-126
22. Gong B., et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126 (2006) 775-788
23. Wood M.A., et al. Ubiquitin C-terminal hydrolase L3 (Uchl3) is involved in working memory. Hippocampus 15 (2005) 610-621
24. Merlo E., and Romano A. Long-term memory consolidation depends on proteasome activity in the crab Chasmagnathus. Neuroscience 147 (2007) 46-52
25. Speese S.D., et al. The ubiquitin proteasome system acutely regulates presynaptic protein turnover and synaptic efficacy. Curr. Biol. 13 (2003) 899-910
26. Willeumier K., et al. Proteasome inhibition triggers activity-dependent increase in the size of the recycling vesicle pool in cultured hippocampal neurons. J. Neurosci. 26 (2006) 11333-11341
27. Juo P., and Kaplan J.M. The anaphase-promoting complex regulates the abundance of GLR-1 glutamate receptors in the ventral nerve cord of C. elegans. Curr. Biol. 14 (2004) 2057-2062
28. Dreier L., et al. LIN-23-mediated degradation of beta-catenin regulates the abundance of GLR-1 glutamate receptors in the ventral nerve cord of C. elegans. Neuron 46 (2005) 51-64
29. Patrick G.N., et al. Ubiquitin-mediated proteasome activity is required for agonist-induced endocytosis of GluRs. Curr. Biol. 13 (2003) 2073-2081
30. Colledge M., et al. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron 40 (2003) 595-607
31. Deng P.Y., and Lei S. Long-term depression in identified stellate neurons of juvenile rat entorhinal cortex. J. Neurophysiol. 97 (2007) 727-737
32. Ehlers M.D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 6 (2003) 231-242
33. Bingol B., and Schuman E.M. Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 441 (2006) 1144-1148
34. Shen H., et al. NAC1 regulates the recruitment of the proteasome complex into dendritic spines. J. Neurosci. 27 (2007) 8903-8913
35. Upadhya S.C., et al. Differential regulation of proteasome activity in the nucleus and the synaptic terminals. Neurochem. Int. 48 (2006) 296-305
36. Chain D.G., et al. Mechanisms for generating the autonomous cAMP-dependent protein kinase required for long-term facilitation in Aplysia. Neuron 22 (1999) 147-156
37. Zhao Y., et al. The ubiquitin proteasome system functions as an inhibitory constraint on synaptic strengthening. Curr. Biol. 13 (2003) 887-898
38. Fenteany G., et al. A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3358-3362
39. Upadhya S.C., et al. Ubiquitin-proteasome-mediated CREB repressor degradation during induction of long-term facilitation. J. Neurochem. 91 (2004) 210-219
40. Hegde, A.N. et al. The proteasome plays differential spatial and temporal roles in late phase longterm potentiation [abstract]. In Soc. Neurosci. Abstr.: 2006; Atlanta
41. Fonseca R., et al. A balance of protein synthesis and proteasome-dependent degradation determines the maintenance of LTP. Neuron 52 (2006) 239-245
42. Karpova A., et al. Involvement of protein synthesis and degradation in long-term potentiation of Schaffer collateral CA1 synapses. J. Neurosci. 26 (2006) 4949-4955
43. Hou L., et al. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51 (2006) 441-454
44. de Vrij F.M., et al. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. Prog. Neurobiol. 74 (2004) 249-270
45. Upadhya S.C., and Hegde A.N. Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies. Curr. Pharm. Des. 11 (2005) 3807-3828
46. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 (2006) 780-786
47. McNaught K.S., et al. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann. Neurol. 56 (2004) 149-162
48. McNaught K.S., et al. Proteasome inhibitor-induced model of Parkinson's disease. Ann. Neurol. 60 (2006) 243-247
49. Kordower J.H., et al. Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Ann. Neurol. 60 (2006) 264-268
50. van Leeuwen F.W., et al. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279 (1998) 242-247
51. Lam Y.A., et al. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9902-9906
52. Tan Z., et al. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ. 14 (2007) 1721-1732
53. Kim T.W., et al. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272 (1997) 11006-11010
54. Wilson S.M., et al. Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat. Genet. 32 (2002) 420-425
55. Anderson C., et al. Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J. Neurochem. 95 (2005) 724-731
56. Crimmins S., et al. Transgenic rescue of ataxia mice with neuronal-specific expression of ubiquitin-specific protease 14. J. Neurosci. 26 (2006) 11423-11431
57. Komatsu M., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006) 880-884
58. Hara T., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006) 885-889
59. Ding W.X., et al. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol. 171 (2007) 513-524
60. Pandey U.B., et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447 (2007) 859-863
61. Bjorkoy G., et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171 (2005) 603-614
62. Jiang Y.H., et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21 (1998) 799-811
63. DiAntonio A., et al. Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 412 (2001) 449-452
64. Keck S., et al. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 85 (2003) 115-122
65. Kishino T., et al. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15 (1997) 70-73
66. Matsuura T., et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet. 15 (1997) 74-77
67. Saigoh K., et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23 (1999) 47-51
68. Davies S.W., et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 (1997) 537-548
69. Kitada T., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
70. Leroy E., et al. The ubiquitin pathway in Parkinson's disease. Nature 395 (1998) 451-452
71. Shimura H., et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293 (2001) 263-269
72. Middleton F.A., et al. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22 (2002) 2718-2729
73. Altar C.A., et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol. Psychiatry 58 (2005) 85-96